Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis

Abstract Predisposition to autoimmunity and inflammatory disorders is observed in patients with fragile X-associated syndromes. These patients have increased numbers of CGG triplets in the 5’ UTR region of FMR1 (Fragile X Mental Retardation 1) gene, that affects its expression. FMR1 is decreased in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Scott Thomas, Odessa-Maud Fayet, Frédérique Truffault, Elie Fadel, Bastien Provost, Abderaouf Hamza, Sonia Berrih-Aknin, Jean-Paul Bonnefont, Rozen Le Panse
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/9deab7876400409a9bac10a74b0c4241
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9deab7876400409a9bac10a74b0c4241
record_format dspace
spelling oai:doaj.org-article:9deab7876400409a9bac10a74b0c42412021-11-21T12:39:52ZAltered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis10.1186/s12974-021-02311-y1742-2094https://doaj.org/article/9deab7876400409a9bac10a74b0c42412021-11-01T00:00:00Zhttps://doi.org/10.1186/s12974-021-02311-yhttps://doaj.org/toc/1742-2094Abstract Predisposition to autoimmunity and inflammatory disorders is observed in patients with fragile X-associated syndromes. These patients have increased numbers of CGG triplets in the 5’ UTR region of FMR1 (Fragile X Mental Retardation 1) gene, that affects its expression. FMR1 is decreased in the thymus of myasthenia gravis (MG) patients, a prototypical autoimmune disease. We thus analyzed the number of CGG triplets in FMR1 in MG, and explored the regulatory mechanisms affecting thymic FMR1 expression. We measured the number of CGGs using thymic DNA from MG and controls, but no abnormalities in CGGs were found in MG that could explain thymic decrease of FMR1. We next analyzed by RT-PCR the expression of FMR1 and its transcription factors in thymic samples, and in thymic epithelial cell cultures in response to inflammatory stimuli. In control thymuses, FMR1 expression was higher in males than females, and correlated with CTCF (CCCTC-binding factor) expression. In MG thymuses, decreased expression of FMR1 was correlated with both CTCF and MAX (Myc-associated factor X) expression. Changes in FMR1 expression were supported by western blot analyses for FMRP. In addition, we demonstrated that FMR1, CTCF and MAX expression in thymic epithelial cells was also sensitive to inflammatory signals. Our results suggest that FMR1 could play a central role in the thymus and autoimmunity. First, in relation with the higher susceptibility of females to autoimmune diseases. Second, due to the modulation of its expression by inflammatory signals that are known to be altered in MG thymuses.Scott ThomasOdessa-Maud FayetFrédérique TruffaultElie FadelBastien ProvostAbderaouf HamzaSonia Berrih-AkninJean-Paul BonnefontRozen Le PanseBMCarticleFragile X syndromesAutoimmunityFMR1ThymusMyasthenia gravisInflammatory cytokinesNeurology. Diseases of the nervous systemRC346-429ENJournal of Neuroinflammation, Vol 18, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Fragile X syndromes
Autoimmunity
FMR1
Thymus
Myasthenia gravis
Inflammatory cytokines
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Fragile X syndromes
Autoimmunity
FMR1
Thymus
Myasthenia gravis
Inflammatory cytokines
Neurology. Diseases of the nervous system
RC346-429
Scott Thomas
Odessa-Maud Fayet
Frédérique Truffault
Elie Fadel
Bastien Provost
Abderaouf Hamza
Sonia Berrih-Aknin
Jean-Paul Bonnefont
Rozen Le Panse
Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
description Abstract Predisposition to autoimmunity and inflammatory disorders is observed in patients with fragile X-associated syndromes. These patients have increased numbers of CGG triplets in the 5’ UTR region of FMR1 (Fragile X Mental Retardation 1) gene, that affects its expression. FMR1 is decreased in the thymus of myasthenia gravis (MG) patients, a prototypical autoimmune disease. We thus analyzed the number of CGG triplets in FMR1 in MG, and explored the regulatory mechanisms affecting thymic FMR1 expression. We measured the number of CGGs using thymic DNA from MG and controls, but no abnormalities in CGGs were found in MG that could explain thymic decrease of FMR1. We next analyzed by RT-PCR the expression of FMR1 and its transcription factors in thymic samples, and in thymic epithelial cell cultures in response to inflammatory stimuli. In control thymuses, FMR1 expression was higher in males than females, and correlated with CTCF (CCCTC-binding factor) expression. In MG thymuses, decreased expression of FMR1 was correlated with both CTCF and MAX (Myc-associated factor X) expression. Changes in FMR1 expression were supported by western blot analyses for FMRP. In addition, we demonstrated that FMR1, CTCF and MAX expression in thymic epithelial cells was also sensitive to inflammatory signals. Our results suggest that FMR1 could play a central role in the thymus and autoimmunity. First, in relation with the higher susceptibility of females to autoimmune diseases. Second, due to the modulation of its expression by inflammatory signals that are known to be altered in MG thymuses.
format article
author Scott Thomas
Odessa-Maud Fayet
Frédérique Truffault
Elie Fadel
Bastien Provost
Abderaouf Hamza
Sonia Berrih-Aknin
Jean-Paul Bonnefont
Rozen Le Panse
author_facet Scott Thomas
Odessa-Maud Fayet
Frédérique Truffault
Elie Fadel
Bastien Provost
Abderaouf Hamza
Sonia Berrih-Aknin
Jean-Paul Bonnefont
Rozen Le Panse
author_sort Scott Thomas
title Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
title_short Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
title_full Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
title_fullStr Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
title_full_unstemmed Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
title_sort altered expression of fragile x mental retardation-1 (fmr1) in the thymus in autoimmune myasthenia gravis
publisher BMC
publishDate 2021
url https://doaj.org/article/9deab7876400409a9bac10a74b0c4241
work_keys_str_mv AT scottthomas alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT odessamaudfayet alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT frederiquetruffault alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT eliefadel alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT bastienprovost alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT abderaoufhamza alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT soniaberrihaknin alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT jeanpaulbonnefont alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
AT rozenlepanse alteredexpressionoffragilexmentalretardation1fmr1inthethymusinautoimmunemyastheniagravis
_version_ 1718418903031349248